Vertex Pharmaceuticals (VRTX) Construction in Progress (2011 - 2012)
Vertex Pharmaceuticals' Construction in Progress was $223.1 million in Q3 2012.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Construction in Progress (2011 - 2012) Analysis & Trends
At the end of FY2011, Construction in Progress at Vertex Pharmaceuticals came in at $55.07 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | - |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | - |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | - |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | - |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | - |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | - |
API Access
Vertex Pharmaceuticals Construction in Progress API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=construction-in-progress&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "construction-in-progress", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=construction-in-progress&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();